参考文献/References:
[1] POLAK E J,O'CALLAGHAN F,OATEN M.Perceptions of IBD within patient and community samples:a systematic review[J].Psychol Health,2020,35(4):425-448.[2] CHACHU K A,OSTERMAN M T.How to diagnose and treat IBD mimics in the refractory IBD patient who does not have IBD[J].Inflamm Bowel Dis,2016,22(5):1262-1274.[3] BRADLEY S M,RUMSFELD J S,HO P M.Incorporating health status in routine care to improve health care value:the VA patient reported health status assessment(PROST)system[J].Jama,2016,316(5):487-488.[4] WILLIET N,SANDBORN W J,PEYRIN-BIROULET L.Patient-reported outcomes as primary end points in clinical trials of inflammatory bowel disease[J].Clin Gastroenterol Hepatol,2014,12(8):1246-1256.[5] 刘砚燕,姚静静,陈如男,等.患者报告结局测量信息系统(PROMIS)的研究进展[J].现代预防医学,2013,40(13):2440-2443.[6] CELLA D,YOUNT S,ROTHROCK N,et al.The patient-reported outcomes measurement information system(PROMIS):progress of an NIH roadmap cooperative group during its first two years[J].Med Care,2007,45(5):S3-S11.[7] 皋文君,袁长蓉.患者自我报告结局测量信息系统在国外的应用进展[J].中华护理杂志,2018,53(11):1401-1405.[8] 李丹钰,蔡婷婷,臧娴,等.患者报告结局测量信息系统在心血管疾病中的应用进展[J].护士进修杂志,2021,36(4):294-297.[9] SPIEGEL B M,HAYS R D,BOLUS R,et al.Development of the NIH patient-reported outcomes measurement information system(PROMIS)gastrointestinal symptom scales[J].Am J Gastroenterol,2014,109(11):1804-1814.[10]KOCHAR B,MARTIN C F,KAPPELMAN M D,et al.Evaluation of gastrointestinal patient reported outcomes measurement information system(GI-PROMIS)symptom scales in subjects with inflammatory bowel diseases[J].Am J Gastroenterol,2018,113(1):72-79.[11]KAPPELMAN M D,LONG M D,MARTIN C,et al.Evaluation of the patient-reported outcomes measurement information system in a large cohort of patients with inflammatory bowel diseases[J].Clin Gastroenterol Hepatol,2014,12(8):1315-1323.[12]ISHAK W W,PAN D,STEINER A J,et al.Patient-reported outcomes of quality of life,functioning,and GI/psychiatric symptom severity in patients with inflammatory bowel disease(IBD)[J].Inflamm Bowel Dis,2017,23(5):798-803.[13]BERNSTEIN C N,ZHANG L,LIX L M,et al.The validity and reliability of screening measures for depression and anxiety disorders in inflammatory bowel disease[J].Inflamm Bowel Dis,2018,24(9):1867-1875.[14]FORREST C B,FORREST K D,CLEGG J L,et al.Establishing the content validity of PROMIS pediatric pain interference,fatigue,sleep disturbance,and sleep-related impairment measures in children with chronic kidney disease and Crohn's disease[J].J Patient Rep Outcomes,2020,4(1):11-18.[15]ARVANITIS M,DEWALT D A,MARTIN C F,et al.patient-reported outcomes measurement information system in children with Crohn's disease[J].J Pediatr,2016(174):153-159.[16]BRENNER E J,LONG M D,MANN C M,et al.Responsiveness of the patient-reported outcomes measurement information system(PROMIS)pediatric measures to changes in disease status and quality of life among children and adolescents with Crohn's disease[J].Inflamm Bowel Dis,2021,27(3):344-351.[17]CONLEY S,JEON S,PROCTOR D D,et al.Longitudinal changes in symptom cluster membership in inflammatory bowel disease[J].J Nurs Scholarsh,2018,50(5):473-481.[18]CONLEY S,PROCTOR D D,JEON S,et al.Symptom clusters in adults with inflammatory bowel disease[J].Res Nurs Health,2017,40(5):424-434.[19]LEE A D,SPIEGEL B M,HAYS R D,et al.Gastrointestinal symptom severity in irritable bowel syndrome,inflammatory bowel disease and the general population[J/OL]. [2016-12-16].https://pubmed.ncbi.nlm.nih.gov/27981684/.[20]ONA S,JAMES K,ANANTHAKRISHNAN A N,et al.Association between vulvovaginal discomfort and activity of inflammatory bowel diseases[J].Clin Gastroenterol Hepatol,2020,18(3):604-611.[21]ELURI S,CROSS R K,MARTIN C,et al.Inflammatory bowel diseases can adversely impact domains of sexual function such as satisfaction with sex life[J].Dig Dis Sci,2018,63(6):1572-1582.[22]ZEITZ J,AK M,MULLER-MOTTET S,et al.Pain in IBD patients:very frequent and frequently insufficiently taken into account[J/OL].[2016-06-22]. https://pubmed.ncbi.nlm.nih.gov/27332879/.[23]FALLING C L,STEBBINGS S,BAXTER D G,et al.Central sensitization inventory mediates the relationship between inflammatory bowel disease activity and worse musculoskeletal pain experiences[J].Pain Pract,2020,20(1):24-33.[24]CONLEY S,JEON S,LEHNER V,et al.Sleep characteristics and rest-activity rhythms are associated with gastrointestinal symptoms among adults with inflammatory bowel disease[J].Dig Dis Sci,2021,66(1):181-189.[25]QAZI T,VERMA R,HAMILTON M J,et al.The use of actigraphy differentiates sleep disturbances in active and inactive Crohn's disease[J].Inflamm Bowel Dis,2019,2(6):1044-1053.[26]MANCINA R M,PAGNOTTA R,PAGLIUSO C,et al.Gastrointestinal symptoms of and psychosocial changes in inflammatory bowel disease:a nursing-led cross-sectional study of patients in clinical remission[J].Medicina(Kaunas),2020,56(1):45-54.[27]ARRUDA J M,BOGETZ A L,VELLANLI S,et al.Yoga as adjunct therapy for adolescents with inflammatory bowel disease:A pilot clinical trial[J].Complement Ther Med,2018,41(6):99-104.[28]STEVENS B W,BORREN N Z,VELONIAS G,et al.Vedolizumab therapy is associated with an improvement in sleep quality and mood in inflammatory bowel diseases[J].Dig Dis Sci,2017,62(1):197-206.[29]LEE C K,MELMED G Y,MANN A,et al.A Multidisciplinary approach to biopsychosocial care for adults with inflammatory bowel disease:a pilot study[J].Inflamm Bowel Dis,2018,24(12):2550-2554.[30]SINGH S,DULAI P S,ZARRINPAR A,et al.Obesity in IBD:epidemiology,pathogenesis,disease course and treatment outcomes[J].Nat Rev Gastroenterol Hepatol,2017,14(2):110-121.[31]JAIN A,NGUYEN N H,PROUDFOOT J A,et al.Impact of obesity on disease activity and patient-reported outcomes measurement information system(PROMIS)in inflammatory bowel diseases[J].Am J Gastroenterol,2019,114(4):630-639.[32]ANANTHAKRISHNAN A N,LONG M D,MARTIN C F,et al.Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis[J].Clin Gastroenterol Hepatol,2013,11(8):965-971.(本文编辑:沈园园)